BOOK OF MEME (MEME) Enters Top 100 Crypto Assets Days After
The new meme coin’s market cap is now well above $1 billion.
The Solana blockchain has become the home of many new and popular meme coins that have garnered the community’s attention during this bull cycle. This has pushed not only their prices up but also SOL’s.
The latest such craze is called BOOK OF MEME and was launched earlier this week. It quickly skyrocketed by triple and quadruple digits in days and has now entered the top 100 cryptocurrencies by market cap after a Binance listing.
CryptoPotato reported earlier that a savvy investor has turned 50 SOL into 767 SOL by investing in BOME’s pre-sale.
Just a day later, BOME grasped the attention of major cryptocurrency exchanges, and the subsequent listing pushed its price to new heights.
Another major exchange – Binance – decided to join the craze by listing the following four trading pairs starting earlier today (March 16)
Binance made sure to warn its users that BOME is a new token that could face enhanced volatility, especially in its early days of existence. This has definitely been the case over the past 24 hours as well, and the asset has soared by more than 140% once again.
Consequently, BOOK OF MEME now has a market capitalization of over $1.3 billion. This has placed it as the 88th largest cryptocurrency by this metric, which is an impressive achievement, given the fact that it was launched days ago.
As previously reported , meme coins, such as SHIB, DOGE, PEPE, and newcomers like WIF and BONK, have charted massive gains during this bull cycle.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

